Nature Reviews Cancer (2019) https://doi.org/10.1038/s41568-019-0182-0 Published online 22 July 2019

In the originally published Research Highlight, the ubiquitin ligase targeting BACH1 for degradation was incorrectly stated as CBL1–FBXO22. It should have read CRL1–FBXO22. This has now been corrected in all versions of the original Research Highlight.